Byetta
Facts from the Community
From the BioVenturist base
Sales:
| Amount | Currency | Year | Area | Company Reporting |
|---|---|---|---|---|
|
|
|||
|
|
|||
|
|
Developed by:
Stage of development:
Indication or disease:
| Disease | Phase of development |
|---|---|
therapeutic molecule:
We can tell you that Byetta is a…
If you know more about Byetta, you can add more facts here »
Similar topics in Freebase
-
Exenatide Nasal
-
RotaTeq
-
Carticel
-
Exenatide Once Weekly
-
Pegfilgrastim
A long-acting pegylated form of a recombinant therapeutic agent which is chemically identical to or similar to an endogenous human granulocyte colony-stimulating factor (G-CSF). Produced endogenously by monocytes, fibroblasts, and endothelial cells, G-CSF binds to and activates specific cell... -
Tositumomab
Tositumomab is a drug for the treatment of follicular lymphoma. It is a IgG2a anti-CD20 monoclonal antibody derived from immortalized mouse cells. Tositumomab is applied in a sequential infusion followed by iodine (I) tositumomab, which is the same antibody covalently bound to the radionuclide...
You can help improve this topic by adding more facts here
